Relevant bibliographies by topics / HIV treatment adherence

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'HIV treatment adherence'

Author: Grafiati
Published: 4 June 2021
Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HIV treatment adherence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HIV treatment adherence"

1

Cooper, Curtis L., and Ed Mills. "Comparison of first antiretroviral treatment duration and outcome in HIV, HIV–HBV and HIV–HCV infection." International Journal of STD & AIDS 18, no. 8 (August 1, 2007): 546–50. http://dx.doi.org/10.1258/095646207781439838.

Full text
Abstract:
Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection may differentially influence HIV treatment duration and outcome. This was assessed at The Ottawa Hospital Immunodeficiency Clinic in first-time highly active antiretroviral therapy (HAART) recipients visited between January 2000 and December 2004. Of 968 patients, 526/700 (75%) HIV, 173/230 (75%) HIV–HCV and 30/38 (79%) HIV–HBV-infected patients initiated HAART. Co-infected patients stopped treatment sooner (HBV – 10 months, HCV – 9 months) than HIV mono-infected (17 months) ( P<0.001). Injection drug history predicted shorter treatment duration (odds ratio [OR]1.59, P<0.001). Use of non-nucleoside-reverse-transcriptase-inhibitor-containing HAART (OR 0.76, P<0.01) and low-dose ritonavir (<400 mg twice daily)-based HAART (OR 0.83, P = 0.06) predicted longer treatment duration. HCV co-infection did not predict duration of therapy (OR 1.19, P=0.19) once controlled for by these three variables. Poor adherence was a major explanation for eventual treatment interruption in those with HIV–HCV (22% versus 5% in HIV alone; P<0.001) as was substance abuse (7% versus < 1% in HIV; P<0.001). Metabolic complications resulted in HAART interruption in HIV mono-infection (8%) but not with HBV or HCV co-infection (both <1%; P<0.001). Antiretroviral selection is critical to the longevity of initially prescribed regimens, irrespective of viral hepatitis co-infection. Attention to this and strategies targeting substance abuse and adherence in HIV–HCV are predicted to increase the duration of HAART.
APA, Harvard, Vancouver, ISO, and other styles
2

Wagner, Glenn, Karen Chan Osilla, Jeffrey Garnett, Bonnie Ghosh-Dastidar, Laveeza Bhatti, Matthew Bidwell Goetz, and Mallory Witt. "Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients." AIDS Research and Treatment 2011 (2011): 1–7. http://dx.doi.org/10.1155/2011/903480.

Full text
Abstract:
Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes.Methods. Chart abstracted and survey data were collected on 72 HIV patients who had received pegylated interferon and ribavirin to assess correlates of treatment adherence, completion, and sustained virologic response (SVR).Results. Nearly half (46%) the sample had active psychiatric problems and 13% had illicit drug use at treatment onset; 28% reported <100% treatment adherence, 38% did not complete treatment (mostly due to virologic nonresponse), and intent to treat SVR rate was 49%. Having a psychiatric diagnosis was associated with nonadherence, while better HCV adherence was associated with both treatment completion and SVR.Conclusions. Good mental health may be an indicator of HCV treatment adherence readiness, which is in turn associated with treatment completion and response, but further research is needed with new HCV treatments emerging.
APA, Harvard, Vancouver, ISO, and other styles
3

Sharma, B., and K. Joshi. "Treatment adherence of antiretroviral therapy among people living with HIV/AIDS." Journal of Chitwan Medical College 6, no. 3 (February 20, 2017): 56–61. http://dx.doi.org/10.3126/jcmc.v6i3.16701.

Full text
Abstract:
Adherence to Antiretroviral therapy (ART)is a principle predictor for the success of Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome treatment. Highly Active Antiretroviral Therapy (HAART) has led to the reduction of mortality and the improvement of the quality of people living with HIV/AIDS. It has been estimated that at least 95% adherence with therapy is required to reduce HIV viral load. Non-adherence to treatment can lead to inadequate suppression of viral replication, continued destruction of CD4 cells, progressive decline in immune function and disease progression. The aim of the study is to assess treatment adherence of antiretroviral therapy among people living with HIV/AIDS at Seti Zonal Hospital, Kailali. A descriptive cross-sectional study was conducted among 160 people living with HIV/AIDS in ART Clinic, Seti Zonal Hospital, Kailali. Non-probability purposive sampling technique was used for data collection between 22/03/2071 to 02/04/2071. Informed consent was obtained prior collecting data from self-structured questionnaire using interview technique. Collected data were entered and analyzed by SPSS 17.0 and represented by using percentage, frequency, mean, standard deviation and chi- square test. Results: Among the respondents majority of them were “female” 85(53.1%) sex, from age group “31-45 years” 85 (53.1%), ethnicity “minority group/ Dalit” 76 (47.5%) and education “illiterate” 79 (50.3%). The mean adherence rate for one month was found to be 89.92%. Majority of the respondents were adherent to ART 96 (60%). Regarding non-adherence the major barrier was “forgetting” 52 (45.6%). There is statistically significant association between age of the respondents (p=0.04), ethnicity (p=0.03) and prescribed ARV regimen (p=0.02) with drug adherence. More than half of the respondents were adherent to ART. Among non-adherent, the most of them reported “forgetting to take drug”. Non adherence patient and family members can be addressed with proper counseling and motivation for their drug compliance.
APA, Harvard, Vancouver, ISO, and other styles
4

Stirratt, Michael J., and Christopher M. Gordon. "HIV Treatment Adherence Research and Intervention." Journal of HIV/AIDS & Social Services 6, no. 1-2 (March 27, 2007): 9–22. http://dx.doi.org/10.1300/j187v06n01_02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miguez-Burbano, Maria Jose, Luis Espinoza, and John E. Lewis. "HIV Treatment Adherence and Sexual Functioning." AIDS and Behavior 12, no. 1 (February 13, 2007): 78–85. http://dx.doi.org/10.1007/s10461-006-9197-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hornschuh, Stefanie, Janan Janine Dietrich, Celokuhle Tshabalala, and Fatima Laher. "Antiretroviral Treatment Adherence: Knowledge and Experiences among Adolescents and Young Adults in Soweto, South Africa." AIDS Research and Treatment 2017 (2017): 1–8. http://dx.doi.org/10.1155/2017/5192516.

Full text
Abstract:
Human immunodeficiency virus (HIV) management of adolescents and young adults (AYAs) is particularly pertinent to sub-Saharan Africa, where the pediatric HIV burden is marked. Antiretroviral treatment (ART) adherence is a major challenge for AYAs. This qualitative study explored knowledge and experiences of adherence amongst AYAs attending treatment at the Perinatal HIV Research Unit (PHRU), Soweto, South Africa. Four focus group discussions (FGDs) and eight in-depth interviews (IDIs) were conducted with HIV-infected 15–25-year-old ART recipients. Transcripts were coded thematically. Participants (n=26) were aged median 18.5 years, 59.1% female and 69.2% virally suppressed <400 cp/ml. Three main themes emerged during FGDs and IDIs: (i) correct knowledge about how to be adherent, benefits, and nonadherence consequences, (ii) social, personal, and medication-related barriers to adherence, and (iii) reminder, concealment, and motivational strategies to optimize adherence. Interventions to improve AYA adherence could focus on practical strategies, including status disclosure and medication concealment.
APA, Harvard, Vancouver, ISO, and other styles
7

Sánchez Peña, Sara, María del Mar Pastor Bravo, Miguel Ángel Cánovas Tomás, Pilar Almansa-Martínez, Caridad Peñalver Guillen, and Ismael Jiménez-Ruiz. "Factores relacionados con la adherencia al tratamiento antirretroviral en mujeres con VIH: Un estudio mixto con diseño secuencial." Enfermería Global 20, no. 2 (April 1, 2021): 1–34. http://dx.doi.org/10.6018/eglobal.437711.

Full text
Abstract:
Introducción: El VIH/Sida afecta cada vez a más mujeres. La adherencia al tratamiento antirretroviral es decisiva en la calidad de vida de las personas infectadas. Objetivos: El objetivo del estudio es determinar el grado de adherencia manifestada en un grupo de mujeres con VIH/Sida, con TAR e identificar los factores y circunstancias que influyen en su adherencia.Metodología: Se ha realizado un estudio con diseño mixto secuencial explicativo. Los sujetos de estudio son 86 mujeres diagnosticadas con VIH/Sida en tratamiento con TARGA. Resultados: Se recogieron datos cualitativos de 18 de ellas. El 59,3% de las participantes son no adherentes. Los factores determinantes de la no adherencia son el grado académico, edad, ingresos, así como factores personales, interpersonales como el apoyo sociofamiliar, estigma percibido y autoestigma y factores relativos a la enfermedad y tratamiento. Conclusión: Los cuidados de enfermería deben abordar con enfoque de género aquellos factores psicosociales e individuales del proceso de adherencia. Background: HIV/AIDS is affecting more and more women. Adherence to antiretroviral treatment (ART) is decisive for those infected to achieve quality of life. Purpose: The aim of the present study is to determine the degree of adherence displayed by a group of women with HIV/AIDS and to identify those factors and circumstances which might influence their adherence to ART. Method: A sequential mixed model research design was applied. The subjects studied consisted of 86 women diagnosed with HIV/AIDS and treated with ART. Findings and discussion: Qualitative data were collected from 18 of these women. 59.3% of participants were non-adherents. The determining factors for non-adherence were level of education, age, income, as well as personal and/or interpersonal factors such as socio-familial support, perceived stigma, self-stigma and factors related to disease and treatment. Nursing care should take a gender-focused approach towards those psychological and personal factors inherent in the adherence process.
APA, Harvard, Vancouver, ISO, and other styles
8

Stirratt, Michael J., and Christopher M. Gordon. "Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research." Current HIV/AIDS Reports 5, no. 4 (November 2008): 186–92. http://dx.doi.org/10.1007/s11904-008-0027-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wagner, Glenn J., Mary Slaughter, and Bonnie Ghosh-Dastidar. "Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda." Journal of the International Association of Providers of AIDS Care (JIAPAC) 16, no. 1 (November 30, 2016): 91–97. http://dx.doi.org/10.1177/2325957416677121.

Full text
Abstract:
We examined the relationship between depression (symptom type, diagnostic severity, and change over time) and adherence to HIV antiretroviral therapy (ART) with data from 3 longitudinal studies (N = 1021) of patients starting ART in Uganda. The Patient Health Questionnaire was used to assess depressive symptoms (total score; somatic and cognitive subscales) and categorize severity level. At baseline, 9% had major depression and 30% had minor depression; 82% were adherent (reported no missed ART doses in the past 7 days) at month 6 and 85% at month 12. Controlling for demographic and medical covariates, multivariate random-effects logistic regression models revealed that change in depression was not related to adherence; however, baseline total depression symptoms and cognitive symptoms in particular as well as major and minor depression were significant predictors of adherence. These findings highlight the need for early identification and aggressive treatment of depression to optimize ART adherence.
APA, Harvard, Vancouver, ISO, and other styles
10

Johnson, Mallory O., Torsten B. Neilands, Samantha E. Dilworth, Stephen F. Morin, Robert H. Remien, and Margaret A. Chesney. "The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)." Journal of Behavioral Medicine 30, no. 5 (June 23, 2007): 359–70. http://dx.doi.org/10.1007/s10865-007-9118-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HIV treatment adherence"

1

Södergård, Björn. "Adherence and Readiness to Antiretroviral Treatment." Doctoral thesis, Uppsala University, Department of Pharmacy, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7282.

Full text
Abstract:

Antiretroviral therapy places extraordinarily high demands on adherence, since non-adherence affects both individuals and society due to the spread of resistant viral strains. The aims of the thesis were to investigate the prevalence of adherence in Swedish HIV-infected patients, changes in adherence over time, and factors associated with adherence, including patients’ readiness to adhere. Further, to investigate the collaboration between nurses, doctors and pharmacists after the introduction of a HIV-clinic satellite pharmacy. Data were collected via two cross-sectional patient surveys in 1998 and 2002, qualitative interviews with health care personnel at a major HIV clinic, and a nation-wide, cross-sectional patient survey in 2003-2004.

The level of adherence improved from 28% in 1998 to 57% in 2002, possibly due to simplified treatment and a new multi-professional treatment model at the clinic. The proportion of adherent patients was 63% in the nationwide survey. Factors associated with adherence were high age, high quality patient-provider relationships, no drug or alcohol problems and shorter time on treatment.

A hypothesized structural equational model, using readiness and adherence as separate latent concepts, was tested and found to support readiness as a distinct factor influencing adherence.

The health care personnel believed that conventional pharmacies had several disadvantages in serving the HIV infected population. They found the HIV-clinic satellite pharmacy valuable, since it contributed to increased communication and trust between the health care professions, and improved teamwork in medication management.

In conclusion, the level of adherence increased over time, and several factors associated with adherence were identified. Improved collaboration between health care professionals may enhance treatment support, and increased attention should be given to interventions that focus on the individual’s readiness for behavioural change in order to optimize treatment outcomes.

APA, Harvard, Vancouver, ISO, and other styles
2

Masokoane, Kgomotso Quentinne. "Adherence and non-adherence to antiretroviral treatment in HIV people in Port Elizabeth." Thesis, Nelson Mandela Metropolitan University, 2009. http://hdl.handle.net/10948/1185.

Full text
Abstract:
The introduction of antiretroviral drugs (ARVs) in 1996 transformed the treatment of HIV and AIDS, improving the quality and greatly prolonging the lives of many infected people. HIV (Human Immunodeficiency Virus) is the virus that is believed to cause AIDS. AIDS (Acquired Immune Deficiency Syndrome) is the collection of illnesses or symptoms that ultimately results in death. Antiretroviral (ARVs) drugs or Highly Active Antiretroviral Therapy (HAART) is the treatment that has been applied to combat the HI virus in a bid to slow down the progression of AIDS and ultimately prolong the life of the infected individual. The study aimed to explore and describe the factors contributing to adherence and non-adherence to ARVs in individuals on treatment. A sample of 81 individuals who have been on ARV and HAART treatment for six months or more was used. The methodology used was exploratory-descriptive and the data obtained was quantitative in nature. A biographical questionnaire and questionnaire with questions aimed at ascertaining the possible factors that contribute to individuals either adhering to or defaulting on their treatment, such as side effects and cost of treatment, was administered. The data obtained was analysed by means of descriptive statistics and frequency counts. The results of the study showed that the sample had a fairly high level of adherence. The factors that could undermine adherence were identified as lack of support, as familial and health provider support acts as a motivator to adhere; substance abuse as it can lead to forgetting to take treatment; unemployment and poverty, as these can lead to an inability to return for follow up clinic visits or failure to have food to take with the pills; and the type of treatment regimen whereby the more complex the treatment is the more likely it is that adherence will be difficult to maintain. Suggestions were made as to future research involving antiretroviral therapy (ART). Finally the limitations as well as the value of the research were outlined.
APA, Harvard, Vancouver, ISO, and other styles
3

Phalafala, Mathatho Samuel. "The effects of HIV status disclosure on antiretroviral treatment adherence." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96973.

Full text
Abstract:
Thesis (MSc)--Stellenbosch University, 2015.
ENGLISH ABSTRACT: Successful antiretroviral therapy (ART) depends on appropriate use of antiretroviral agents; which ultimately prevents replication of Human Immunodeficiency Virus (HIV) thus delaying clinical progression of the disease. This study explored how HIV status disclosure affects adherence to antiretroviral therapy at Mamelodi Hospital, using a convenience sampling method with a sample size of 50 adults above 18 years who were on treatment for a minimum of two years prior to the study. An interview protocol was used to uncover patients’ demographics, sexual orientation, and HIV status disclosure, adherence to antiretroviral drugs, drug side effects, how often they missed their doses and how HIV status disclosure / non-disclosure affected their adherence to treatment. Patients’ medical records were assessed to validate and correlate the information obtained from the interviews. The scientific test results used were the CD4count and Viral loads which are used to monitor the HIV/AIDS disease progression. All partakers involved in the study made their HIV status known and reported taking their medicines regularly. The patients’ CD4 count and VL were verified, the CD4 count has shown an upward trend while the VL load showed a downward trend in keeping with patients who are adhering to ART. The majority of participants (54% or 27 patients) reported they had never skipped taking their medication. The participants also reported they had taken their medicine in front of other people and they constituted 74% (37) of the group. Of this 74%, 78.38% (29 patients) said it was because they had disclosed their status. This observation supports the fact that if you have disclosed your HIV status, you have better chances of adhering to prescribed medication. Findings from the study at Mamelodi Hospital revealed that for as long as one has disclosed their HIV status, the outcome of treatment adherence will be better. The only shortfall noted was lack of partakers who did not divulge their HIV status thus a comparison could not be done. It was acknowledged that some participants in the study might have reported disclosure of their HIV status to be in good favour of the researcher to create an impression that they are adhering to their medication. The study has confirmed the existence of a relationship between HIV status disclosure and adherence to ART.
AFRIKAANSE OPSOMMING: Suksessvolle antiretrovirale terapie (ART) hang af van die toepaslike gebruik van antiretrovirale middels, wat replikase van die MI-virus verhoed, en dus die kliniese vordering van die siekte vertraag. Hierdie studie het ondersoek hoe die bekendmaking van MIV-status die gehoorsaamheid tot ART beïnvloed het by die Mamelodi Hospitaal. ‘n Gerieflikheid-streekproef met ‘n groote van 50 volwassenes bo 18 jaar is gebruik en die deelnememers moes ten minste vir twee jaar voor die studie reeds op behandeling gewees het. Data is deur middel van onderhoude ingesamel, met die doel om pasiënte se demografiese inligting, seksuele orientasie, MIV-status, gehoorsaamheid tot ART en newe-effekte van ART in te samel. Pasiënte se mediese rekords is nagegaan om die inligting wat uit die onderhoude verkry is te bevestig. Die wetenskaplike toetse wat gebruik is, was die CD4-telling en virale lading wat gebruik word om MIV/Vigs te monitor. Al die deelnemers het hul MIV-status bekend gemaak en aangedui dat hul hul medikasie gereeld gebruik. Die pasiënte se CD4-tellings en virale lading is bevestig, die CD4-tellings het ‘n opwaartse neiging getoon terwyl die virale lading ‘n afwaartse neighing getoon het. Die meerderheid van die deelnemers (54%) het aangedui dat hul nog nooit hul medikasie oorgeslaan het nie. 74% van die deelnemers het aagedui dat hul hul medikasie voor ander mense neem - hul noem dat dit as gevolg van die feit is dat hul hul status bekend gemaak het. Dit ondersteun die feit dat mense wie hul status bekend maak beter kanse het om gehoorsaam hul medikasie te gebruik. Die studie by die Mamelodi Hospitaal toon dat solank mense hul MIV-status bekend maak, hul meer gehoorsaam is teenoor die gebruik van hul medikasie. Die studie bevestig dus die verband tussen bekendmaking van MIV-status en gehoorsaamheid tot ART.
APA, Harvard, Vancouver, ISO, and other styles
4

Barnes, Shelly Marie. "Investigating the Impact of Patient-Provider Communication on HIV Treatment Adherence." Thesis, University of North Texas, 2016. https://digital.library.unt.edu/ark:/67531/metadc849690/.

Full text
Abstract:
Today over 1.1 million people are living with HIV/AIDS in the United States; over the last 4 decades mortality rates have decreased largely made in part because of advancement in awareness and treatment options. Treatment adherence has long been considered a vital component in decreasing HIV/AIDS related mortality and has proven to reduce the risk of transmission. However not all patients take their medicine as prescribed. This research study, sponsored by The North Central Texas HIV Planning Council explored how Patient and Provider communication impacted treatment adherence. By utilizing a mixed-methods approach survey data and semi-structured interviews were used to collect insights from both Patients and Providers. Data gleaned through the interview process provided a perspective that could not be captured by using quantitative methods alone. The results from this research yielded multiple themes related to patient and provider communication with recommendations as to how The North Central Texas HIV Planning Council could address treatment adherence, such as Providers focus on Patients perceived severity based on their understanding of disease and illness; that side-effects remain a concern for patients and should not be dismissed; and finally that the word AIDS is perceived to be more stigmatized and as such organizations providing HIV/AIDS related services should explore alternative names where the word AIDS in not included.
APA, Harvard, Vancouver, ISO, and other styles
5

Ngugi, Pearl. "Response and adherence of HIV positive women to cervical cancer treatment." Thesis, Nelson Mandela Metropolitan University, 2011. http://hdl.handle.net/10948/d1014129.

Full text
Abstract:
It is estimated that 6742 South African women are diagnosed with cervical cancer and 3681 women die from the disease every year. In 1993, The Centers for Disease Control declared cervical cancer an Acquired Immunodeficiency Syndrome defining illness. Apart from persistent human papillomavirus infection, HIV infection is the most common co-factor contributing to cervical cancer in South Africa. Studies have noted that in HIV positive women, there has been an occurrence of faster progression to more advanced stages of cervical cancer with high cases of treatment failure and recurrence. There is limited literature available regarding the prognosis of HIV positive women who suffer from cervical cancer. Women who are HIV positive and have cervical cancer have not been evaluated in detail regarding their response and adherence to cervical cancer treatment. Standard treatment protocols for this set of patients have not been defined. The aim of this study was to assess how HIV positive women who have been diagnosed with cervical cancer responded and adhered to cervical cancer therapy which includes: curative radiotherapy; curative chemotherapy; concurrent chemoradiation or palliative radiotherapy. The study also evaluated the effects of the concurrent use of antiretrovirals and cervical cancer treatment. This was done to determine whether invasive cervical cancer in women who were HIV positive could be managed using the same treatment protocols as patients who were HIV negative. A historical cohort design was employed for the study. The study was conducted at the Oncology Department of a tertiary level hospital located in the Eastern Cape Province, South Africa. The total sample consisted of 196 medical records of women diagnosed with cervical cancer between 2005 and 2008. One hundred women were HIV negative, 83 were HIV positive and the HIV status of 13 women could not be determined. The records were audited over a period of two years from the date of diagnosis. The term „complete response‟ referred to patients who had no recurrence of cervical cancer and no evidence of metastases after undergoing treatment. At one month following treatment there was a significant difference in the incidence of complete response between the HIV positive patients and the HIV negative patients (Chi2 = 16.4, d.f. = 1, p = 0.00005, Cramer‟s V = 0.31). The significant difference in response to treatment between the HIV positive patients and the HIV negative patients was maintained at six months after treatment (Chi2 = 15, d.f. = 1, p = 0.00011, Cramer‟s V = 0.34), 12 months after treatment (Chi2 = 20.5, d.f. = 1, p = 0.00001, Cramer‟s V = 0.37), 18 months after treatment (Chi2 = 9.8, d.f. = 1, p = 0.00173, Cramer‟s V = 0.28) and 24 months after treatment (Chi2 = 5.0, d.f. = 1, p = 0.02571, Cramer‟s V = 0.26). At each of these intervals, cases of treatment failure and metastases were significantly higher in the HIV positive women than in the HIV negative women. Although there was no significant difference in the incidence of adherence between the HIV negative women, the HIV positive women who were on HAART and the HIV positive women who were not on HAART, there was a significant difference in the incidence of the various reasons for non adherence between the various groups. These reasons included: missed scheduled appointments (Chi2 = 2.9, d.f. = 2, p = 0.02385, Cramer‟s V = 0.31); low blood count (Chi2 = 4.0, d.f. = 2, p = 0.01327, Cramer‟s V = 0.15); radiotherapy induced skin breakdown (Chi2 = 0.6, d.f. = 2, p = 0.04581, Cramer‟s V = 0.16) and radiotherapy induced diarrhoea (Chi2 = 6.9, d.f. = 2, p = 0.03118, Cramer‟s V = 0.19). According to the 2004 National Antiretroviral Treatment Guidelines, cervical cancer patients would fall into the WHO stage IV category of HIV disease thus all patients with confirmed diagnosis of invasive cervical cancer should be commenced on antiretrovirals as soon as the cancer diagnosis is made regardless of their CD4 count. However, in the current study, 13 percent (n= 83) of the HIV positive women were not on antiretrovirals. The study concluded that HIV positive women had a higher incidence of both treatment failure and metastases to cervical cancer treatment. Standard radiotherapy and concurrent chemoradiation cervical cancer treatment protocols should be still be used in both HIV negative patients and HIV positive patients so as not to compromise tumour control. Furthermore, in accordance with the antiretroviral treatment guidelines, all HIV positive patients with cervical cancer should receive antiretrovirals irrespective of their CD4 count.
APA, Harvard, Vancouver, ISO, and other styles
6

Kurtyka, Donald E. "The Effects of a Structured Adherence Intervention to HAART on Adherence and Treatment Response Outcomes." Scholar Commons, 2007. https://scholarcommons.usf.edu/etd/350.

Full text
Abstract:
Background: Adherence to antiretroviral (ARV) medications in excess of 90-95% is necessary for optimal response to suppress HIV replication and to maintain and/or restore immune function. A number of interventions have been shown to improve ARV adherence, but no research has been conducted which evaluates proactive monitoring of pharmacy refill adherence and subsequent intervention when inadequate adherence is identified. Purpose: The purpose of this project was to compare treatment response, pharmacy refill adherence and self-reported medication adherence between two groups of patients: those participating in an AIDS Drug Assistance Program (ADAP) and those participating in a Medicaid-funded medication access program. The ADAP served as a structured adherence intervention (SAI) based on procedural and administrative processes required by the state-managed program Additionally, covariates that can impact adherence were studied including utilization of adherence services and interventions and factors related to HIV disease, antiretroviral agents and sociodemographic factors. Method: This retrospective comparative study examined secondary data to assess 424 patients who received clinical and pharmacy services at one treatment site in 2005. Analysis: Logistic regression was performed to test the effects of the SAI on treatment response (CD4 and HIV RNA response), self-reported adherence, and pharmacy refill adherence while controlling for the covariates. Results: Patients participating in the SAI demonstrated higher levels of both self-reported and pharmacy refill adherence compared to patients receiving usual care. Although patients participating in the SAI program demonstrated better virologic (HIV RNA) responses to HAART compared to patients receiving usual care, immunologic (CD4 lymphocyte) responses to HAART were not significantly different compared to subjects in the usual care program. Conclusion/Discussion: This study provides information on the effects of a structured programmatic intervention on medication adherence and response to treatment and will be used to inform policy decision making at the local and State level.
APA, Harvard, Vancouver, ISO, and other styles
7

Usman, Samuel. "Factors which affect optimal adherence to antiretroviral medications." Thesis, Stellenbosch : University of Stellenbosch, 2010. http://hdl.handle.net/10019.1/4181.

Full text
Abstract:
Thesis (MPhil (Industrial Psychology. Africa Centre for HIV/AIDS Management))--University of Stellenbosch, 2010.
ENGLISH ABSTRACT: The advent of anti-retroviral therapy (ART) has bought hope and reprieve in a previously hopeless situation where there was no available drug to combat the virus with the result that AIDS deaths from chronic, untreated HIV infection became the major cause of morbidity and mortality especially in sub-Saharan Africa where the disease burden is highest. Since March 19, 1987, when the FDA approved Zidovudine for the treatment of AIDS, there has been great improvement in the prognosis and quality of life of HIV infected persons especially in sub- Saharan countries like Nigeria where the burden of HIV disease is high. Even though the treatment of HIV looked promising to all HIV sufferers, there were strict requirements for taking the ARVs, that meant patients had to be able to take the medication more than 95% of the prescribed time. The requirements also involved strict dietary restrictions that further made adherence to these medications very difficult indeed. In addition, the potential for side effects of the medications and its requirement for life-style modifications like abstinence from excess alcohol made sticking to the required regimen very cumbersome and rather patient unfriendly. Therefore, as the use of ARVs became more popular and effective, so did the problem of nonadherence continue to fester and deteriorate even further. Therefore, the problem of lack of optimum adherence to ARVs is one that potentially threatens all the gains of the discovery and use of potent, life-saving ARVs. Hence, there is now a need to look at how best to improve adherence to ARVs in the most innovative, cost-effective and patient-friendly manner. This study argues for the use of simple, locally-driven adherence strategies that overcome the low literacy and excessive alcoholism that are major factors preventing optimal adherence to ARVs amongst patients.
AFRIKAANSE OPSOMMING: Die intrede van anti-retrovirale behandeling het hoop en genade gebring aan ‘n voorheen hopelose situasie waar daar geen behandeling beskikbaar was om die virus te beveg nie, wat daartoe gelei het dat VIGS, as gevolg van MIV-infeksie wat nie behandel is nie, die grootste oorsaak van sterftes in veral Sub-Sahara Afrika is. Sedert 19 Maart 1987, wanneer Zidovudine goedgekeur is vir die behandeling van VIGS, is daar ‘n groot verbetering in die prognose en kwaliteit van lewe van MIV-geinfekteerde mense, veral in Sub-Sahara lande soos Nigerië waar die voorkoms van MIV hoog is. Hoewel de behandeling van MIV vir alle MIV-lyers belowend gelyk het, was daar streng vereistes vir die neem van anti-retrovirale behandeling. Daar was ook streng dieetkundige beperkinge wat die getrouheid tot die behandeling bemoeilik het. Die moontlike newe-effekte van die behandeling en nodige leefstyl veranderinge, soos byvoorbeeld weerhouding van oormatige alkohol gebruik, maak die behandeling redelik pasiënt onvriendelik. Soos die anti-retrovirale behandeling meer gewild en effektief geraak het, het die probleem van ongetrouheid ook toegeneem. Die probleem rondom ongetrouheid tot behandeling bedreig alles wat deur die behandeling gebied kan word. Daar is nou ‘n behoefte daaraan om getrouheid tot anti-retrovirale behandeling te bevorder in die mees innoverende, koste-effektiewe en pasiënt vriendelike manier. Die studie beveel eenvoudige, plaaslik gedrewe getrouheid-strategieë aan wat optimale getrouheid aan behandeling sal verseker.
APA, Harvard, Vancouver, ISO, and other styles
8

Engel, Tania. "Measuring adherence levels to antiretroviral treatment (ART) and assessing certain factors affecting adherence in a state primary health care clinic, Mitchells Plain Community Health Centre, South Africa." Thesis, Stellenbosch : University of Stellenbosch, 2015. http://hdl.handle.net/10019.1/97236.

Full text
Abstract:
Objective. Measuring adherence levels and assessing the impact on adherence to ART (antiretroviral treatment) of the factors: disclosure to partner, partner support, other support and length of time between diagnosis and ART commencement, in a state-run ART clinic at Mitchells Plain Community Health centre. Design. A retrospective case control study was conducted and the information was obtained by means of a file audit. Methods. Every 5th file was selected for the study and 199 participants were chosen based on the inclusion and exclusion criteria. Adherence for each patient was measured using a formula documented in a published study. For the comparison group 82 cases (non-adherent patients) were matched for age and gender with 82 adherent controls. Results. The mean adherence for the initial group of 199 participants was 80.1%. Disclosure to a partner and partner support were not found to significantly affect adherence. The time between HIV diagnosis and ART commencement was also not found to make a statistically significant difference to adherence. There appeared to be an association, though not statistically significant, between other support (not from the partner) and >95% adherence (p= 0.0579). Conclusion. It can be concluded that adherence is probably influenced by a wide variety of factors. More qualitative studies or larger samples are recommended to better assess the impact of partner support and acceptance of HIV on adherence. Approaches to partner disclosure prior to commencing ART should be reviewed. The mean adherence level of 80.1% is an indication that more work is urgently needed to improve adherence levels in state-run clinics in South Africa.
APA, Harvard, Vancouver, ISO, and other styles
9

Mbunyuza, Lungelwa. "Treatment adherence in TB/HIV co-infected patients in Mount Frere, Eastern Cape." University of Western Cape, 2020. http://hdl.handle.net/11394/8051.

Full text
Abstract:
Master of Public Health - MPH
Adequate levels of adherence to treatment for tuberculosis (TB) and HIV at the same time poses a problem for public health in South Africa. TB/HIV co-infected patients face many potential barriers to adherence to treatment for both conditions. There is a need for more knowledge about factors influencing treatment adherence in co-infected patients on concomitant treatment. The aim of this study was to explore the barriers and facilitators to treatment adherence among people co-infected with TB/HIV living in the Alfred Nzo District, Eastern Cape, in order to identify the barriers and facilitators to adherence.
APA, Harvard, Vancouver, ISO, and other styles
10

Weinberger, Beverley Slome Kloss Jacqueline D. "Posttraumatic stress in adolescents with HIV and its relationship with treatment adherence : the role of health beliefs /." Philadelphia, Pa. : Drexel University, 2010. http://hdl.handle.net/1860/3221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HIV treatment adherence"

1

Gupta, Indrani. Determinants of adherence in the antiretroviral treatment programme of the government of India. Delhi: Institute of Economic Growth, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ka'opna, Lana Sue, and Nathan L. Linsk, eds. HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sue, Ka'opua Lana, and Linsk Nathan L, eds. HIV treatment adherence: Challenges for social services. New York, NY: Haworth Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Linsk, Nathan L., and Lana Sue Ka'opna. HIV Treatment Adherence: Challenges for Social Services. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lana Sue, Ph.D. Ka'opua (Editor) and Nathan L. Linsk (Editor), eds. HIV Treatment Adherence: Challenging for Social Services (Journal of HIV/AIDS & Social Services) (Journal of HIV/AIDS & Social Services). Haworth Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Weiss, Jeffrey J., and Michael J. Stirratt. Psychiatric Aspects of Care Engagement and Medication Adherence in Antiretroviral-Based HIV Treatment and Prevention. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0029.

Full text
Abstract:
Care engagement and treatment adherence are directly related to HIV treatment outcomes and to mortality. Active drug use and psychiatric illness such as depressive and addictive disorders are significant barriers to care engagement and treatment adherence among persons living with HIV and those at high risk for HIV infection and eligible for pre-exposure prophylaxis (PrEP). This chapter addresses (1) psychiatric aspects of PrEP for HIV prevention, (2) the care continuum for individuals living with HIV infection, (3) psychiatric determinants of HIV care engagement, (4) behavioral interventions to improve HIV care engagement, (5) psychiatric determinants of antiretroviral (ART) adherence, (6) interventions to improve ART adherence, and (7) implications of research findings for the medical and mental health clinician working with patients with psychiatric illness who are living with HIV or at risk for infection.
APA, Harvard, Vancouver, ISO, and other styles
7

Cozza, Kelly L., Gary H. Wynn, Glenn W. Wortmann, Scott G. Williams, and Rita Rein. Psychopharmacological Treatment Issues in HIV/AIDS Psychiatry. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0042.

Full text
Abstract:
Attention to pharmacokinetics and pharmacodynamics and an understanding of intended effects, side effects, toxicities, and drug interactions are imperative when treating persons with HIV/AIDS. This chapter includes an essential review of drug interaction principles and an overview of current antiretroviral treatment (ART) and known side effects, toxicities, and drug interactions, in text and table format. The chapter concludes with a presentation of psychotropic-antiretroviral treatment issues. Most psychotropics are effective in the treatment of persons with HIV, but some, particularly the pan-inducing antiepileptics, are best avoided or at least should be very carefully monitored. Recognizing the potential for drug–drug interactions allows for more careful monitoring and for consideration of alternative treatments or precautions. Being a pharmacologically knowledgeable multidisciplinary team member can reduce morbidity and mortality in patients. An understanding of antiretroviral therapy and psychopharmacological treatment issues prevents morbidity, supports adherence to medications, and improves quality of life for persons with HIV.
APA, Harvard, Vancouver, ISO, and other styles
8

David, Elizabeth. Psychiatric Illness and Treatment in HIV Populations. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0037.

Full text
Abstract:
The interaction between HIV and mental illness is complex. For many individuals, the psychiatric condition is a preexisting one, predisposing to HIV infection through behavioral factors and risk environment. The risk factors for HIV are well established and involve blood/bodily fluid contact with infected individuals: unprotected sexual behaviors, needle sharing, multiple sexual partners, and fetal/natal exposure. Individuals with preexisting psychiatric illness often engage in risky behaviors with little thought or fear of consequences. This relates to increased emotional immaturity and impulsivity, poor contact with reality, denial and disinhibition, cognitive dysfunction, active thoughts of self-harm, and victimization or impaired judgment. Barriers to treatment, such as distrust of authority, poor communication skills, limited access, lack of motivation, and unstructured lifestyle, result in poor overall health care and delayed diagnosis of all health issues. Diagnosis of mental health issues is frequently challenging, and adherence to treatment is frequently impacted by these same factors.
APA, Harvard, Vancouver, ISO, and other styles
9

Maggi, Julie Diana. The impact of attachment style and the physician-patient relationship on adherence to medication treatment in HIV disease. 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Breitbart, William, and Anna L. Dickerman. Fatigue and HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0024.

Full text
Abstract:
Fatigue is commonly reported by persons with HIV and AIDS and is associated with impaired physical function, reduced quality of life, and suboptimal treatment adherence. Patients regard fatigue as an important condition to be addressed because it is disabling and distressing. In the past, fatigue was overlooked and undertreated by physicians, but clinicians caring for persons with HIV and AIDS have been giving more attention to symptom management and patients’ quality of life. Increased attention to symptom management in HIV and AIDS warrants familiarity with major issues in evaluation and treatment of fatigue. This chapter reviews the definition and assessment of fatigue, prevalence of fatigue in HIV/AIDS and its impact on patients, medical and psychological causes of fatigue, and evidence-based treatment strategies.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HIV treatment adherence"

1

Goldstein, Karen Moore. "Adherence in the Treatment of HIV and Other Infectious Diseases." In Improving Patient Treatment Adherence, 259–88. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-5866-2_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Amico, K. Rivet. "Adherence to HIV Treatment as Prevention and Preexposure Prophylaxis." In Biomedical Advances in HIV Prevention, 69–108. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8845-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Adu-Gyamfi, Eric, and Petter Nielsen. "Leveraging Software Platform Capabilities to Support HIV (ART) Treatment Adherence Management: A Case from Sierra Leone." In Information and Communication Technologies for Development, 35–46. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59111-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vermorken, Jan B. "Where and when to Use Induction Chemotherapy in Head and Neck Squamous Cell Cancer." In Critical Issues in Head and Neck Oncology, 155–79. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_11.

Full text
Abstract:
AbstractThe treatment of locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) is reviewed, highlighting the milestones in systemic therapy in that setting, with focus on the role of induction chemotherapy (ICT). The road to what is now considered the standard ICT regimen, i.e. the TPF (docetaxel/cisplatin/5-FU) regimen is described, and the differences between the European and the American TPF are discussed. The article describes the respective roles of ICT for larynx preservation, for treatment intensification, its role in patients with borderline resectable or unresectable oral cavity cancer, its role as a selection tool for radiotherapy dose de-escalation in patients with oropharyngeal squamous cell cancer (OPSCC) and its potential future role in strategies aiming at synchronous oligometastatic disease.ICT has an established role for organ preservation in advanced laryngeal and hypopharyngeal cancer and the TPF regimen has been validated in that setting. This approach is presently being compared in a randomized controlled trial to concurrent chemoradiotherapy (CCRT), which in many parts of the world is considered the standard organ preservation procedure. There remains uncertainty about the benefit of the sequential approach of ICT followed by CCRT, despite the fact that ICT significantly reduces the occurrence of distant metastases. It is advised that future studies should include patients who have the highest risk to develop distant metastases, in particular patients with low neck nodes and matted nodes. Moreover, further studies in patients with HPV-associated OPSCC at risk for distant failure (T4 or N3 disease) should be considered for that also. These approaches still need to be confirmed in adequately sized randomized controlled trials. Outside clinical trials, the utility of ICT is restricted to uniquely pragmatic clinical scenarios, such as unavoidable delay in radiation or in the situation that RT is not tolerated or feasible. This can happen when there is severe pain from advanced disease or there is impending airway compromise or neurologic dysfunction that necessitates rapid initiation of treatment. In all those circumstances whether within the context of trials or outside trials, it is imperative that the present backbone of ICT, the TPF regimen, is being administered by experienced oncologists, familiar with the necessary protocols and supportive care requirements to ensure patient safety and maximize adherence throughout the treatment.Future areas of research are the role of ICT in strategies whereby ICT is combined with upfront metastases-directed treatments and the usefulness of targeted agents or immune checkpoint inhibitors in the induction setting. Studies in that direction have already started. Finally, the application of radiographic, proteomic and genomic biomarkers will get attention to further define prognostic groups and guide treatment selection with greater precision.
APA, Harvard, Vancouver, ISO, and other styles
5

"The Development and Feasibility of an Intervention to Improve HAART Adherence Among HIV-Positive Patients Receiving Primary Care in Methadone Clinics." In HIV Treatment Adherence, 117–36. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Specialized Adherence Counselors Can Improve Treatment Adherence: Guidelines for Specific Treatment Issues." In HIV Treatment Adherence, 137–54. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Training Substance Abuse Counselors About HIV Medication Adherence." In HIV Treatment Adherence, 155–76. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"More Than Drugs: Voices of HIV-Seropositive Individuals with a History of Substance Use Reveal a Range of Adherence Factors." In HIV Treatment Adherence, 177–96. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Introduction: Addressing Challenges of Adherence to HIV Medications for Social Services Practice, Research, and Training." In HIV Treatment Adherence, 17–24. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"HIV Treatment Adherence Research and Intervention: Current Advances and Future Challenges." In HIV Treatment Adherence, 25–38. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HIV treatment adherence"

1

Notario Dongil, C., A. Perez Fácila, B. Proy Vega, MM Alañón Pardo, P. Araque Arroyo, and JC Valenzuela Gámez. "4CPS-064 Adherence to antiretroviral treatment in patients with HIV." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cane, Reka Maulide, Amilcar Magaco, Carlos Botao, Granelio Tamele, and Francisco Mbofana. "p4.121 Care-seeking Behaviours among hiv-infected adults in mozambique: hiv-related knowledge and adherence to treatment." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pangerti, Fitria Diyah Ayu, Pawito Pawito, and Hanung Prasetya. "Factors Affecting Adherence to Antiretroviral Therapy: Application of Theory of Planned Behavior in Malang, East Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.53.

Full text
Abstract:
Background: Adherence to antiretroviral (ARV) treatment is known as an important component in achieving the success of an optimal HIV therapy program. Poor adherence to antiretroviral therapy (ART) is associated with less effective viral suppression, which creating permanent treatment resistance. The purpose of this study was to examine factors affecting adherence to ARV therapy. Subjects and Method: A cross-sectional study was conducted in Malang, East Java, from September to October 2019. A sample of 200 PLWH was selected by fixed disease sampling. The dependent variable was adherence to ARV therapy. The independent variables were cues to action, perceived susceptibility, perceived benefit, attitude, and CST service. The data were collected by medical record and questionnaire. The data were analyzed by a multiple linear regression. Results: Adherence to ARV therapy in PLWH increased with strong cues to action (OR= 6.40; 95% CI= 3.13 to 13.12; p<0.001), strong perceived susceptibility (OR= 3.61; 95% CI= 1.82 to 7.13; p<0.001), strong perceived benefit (OR= 4.68; 95% CI= 2.37 to 9.28; p<0.001), and positive attitude (OR= 5.39; 95% CI= 2.69 to 10.83; p<0.001). CST service was associated with adherence to ARV therapy but it was statistically non-significant (OR= 0.63; 95% CI= 0.33 to 1.20; p=0.130). Conclusion: Adherence to ARV therapy in PLWH increases with strong cues to action, strong perceived susceptibility, strong perceived benefit, and positive attitude. CST Keywords: Care, support, and treatment service, people living with HIV/AIDS Correspondence: Fitria Diyah Ayu Pangerti. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: ayupangerti13@yahoo.com. Mobile: 081332600710. DOI: https://doi.org/10.26911/the7thicph.02.53
APA, Harvard, Vancouver, ISO, and other styles
4

Lake, Joanita, Kendra Lawrence, Elena Martinez Alonso, Valerie Gonzales, and Joanne LaFleur. "24 Quality appraisal of systematic reviews of HIV treatment adherence and guidance to reduce research waste." In EBM Live Abstracts, July 2019, Oxford, UK. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-ebmlive.105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lobis, Yusuf Bachtiyar, Bhisma Murti, and Hanung Prasetya. "Influences of Peer Support Group and Psychosocio- Economic Determinants on Treatment Compliance in Hiv/Aids Patients in Sragen, Central Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.59.

Full text
Abstract:
Background: Adherence to treatment is important to reduce viral replication, improve clinical and immunological conditions, reduce the risk of developing ARV resistance, and reduce the risk of HIV transmission. Peer support is suspected to be one of the factors driving drug intake adherence in patients with chronic disease. This study aimed to examine the influences of peer support and psychosocio-economic determinants on treatment compliance in HIV/AIDS patients. Subjects and Method: This was a case control design study conducted in Sragen, Central Java, Indonesia. A sample of 200 people with HIV/AIDS (PLWH) was selected by fixed disease sampling. The dependent variable was treatment compliance. The independent variables were knowledge toward HIV/AIDS, perceived benefit, perceived belief, perceived threat, perceived susceptibility, perceived seriousness, perceived barrier, attitude, indirect experience, family support, and peer support. The data were obtained from medical record and questionnaire. The data were analyzed by a multiple logistic regression run on Stata 13. Results: Treatment compliance increased with strong peer support (b= 1.34; 95% CI= 0.31 to 2.38; p= 0.011), strong family support (b= 1.09; 95% CI= 0.16 to 2.02; p= 0.021), knowledge toward HIV/AIDS (b= 1.65; 95% CI= 0.67 to 2.64; p= 0.001), high perceived benefit (b= 1.23; 95% CI= 0.28 to 2.18; p= 0.011), perceived belief (b= 2.05; 95% CI= 0.98 to 3.12; p<0.001), and high perceived threat (b= 1.22; 95% CI= 0.30 to 2.13; p= 0.009). Treatment compliance decreased with negative attitude (b= -2.47; 95% CI= -3.58 to -1.37; p <0.001), low perceived susceptibility (b= -1.26; 95% CI= -2.24 to – 0.27; p= 0.012), low perceived seriousness (b= -1.11; 95% CI= -2.06 to -0.16; p=0.021), high perceived barrier (b= -1.76; 95% CI= -2.81 to -0.70; p= 0.001), and indirect experience (b= -1.10; 95% CI= -2.05 to -0.14; p= 0.024). Conclusion: Treatment compliance increases with strong peer support, strong family support, high knowledge toward HIV/AIDS, high perceived benefit, perceived belief, and high perceived threat. Treatment compliances decrease with negative attitude, low perceived susceptibility, low perceived seriousness, high perceived barrier, and indirect experience. Keywords: HIV/AIDS, treatment compliance, peer support, psychosocial economy Correspondence: Yusuf Bachtiyar Lobis. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: bachtiyar03@gmail.com. Mobile: +628111388841. DOI: https://doi.org/10.26911/the7thicph.02.59
APA, Harvard, Vancouver, ISO, and other styles
6

Usman, Ibiwumi, and Saheed Usman. "P305 Poor adherence predictors and factors associated with treatment failure among HIV seropositive patients in western nigeria." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tshuma, Ndumiso, and Peter Nyasulu. "P4.75 Exploring the relationship between social factors and treatment adherence among clinically stable art patients: structural equation modelling technique." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.570.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rana, Ela, Philippe J. Giabbanelli, Naga H. Balabhadrapathruni, Xiaoyu Li, and Vijay K. Mago. "Exploring the Relationship between Adherence to Treatment and Viral Load through a New Discrete Simulation Model of HIV Infectivity." In SIGSIM-PADS '15: SIGSIM Principles of Advanced Discrete Simulation. New York, NY, USA: ACM, 2015. http://dx.doi.org/10.1145/2769458.2769477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Omonaiye, Olumuyiwa, Pat Nicholson, Snezana Kusljic, and Elizabeth Manias. "P308 Timing of initiation of HIV treatment and level of adherence among pregnant women under option b+ programme in nigeria." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Naldi, Yandri, and Amanah Amanah. "The Role of Patient Characteristics and Group Support to Adherence Treatment in People with HIV/AIDS (PLWHA) in Cirebon City." In International Conference on Agriculture, Social Sciences, Education, Technology and Health (ICASSETH 2019). Paris, France: Atlantis Press, 2020. http://dx.doi.org/10.2991/assehr.k.200402.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HIV treatment adherence"

1

Impact of a community-based, HIV intervention on antiretroviral treatment retention and adherence in Tanzania. Population Council, 2016. http://dx.doi.org/10.31899/hiv7.1013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Adherence to Antiretroviral Therapy in Adults: A Guide for Trainers. Population Council, 2004. http://dx.doi.org/10.31899/hiv15.1000.

Full text
Abstract:
Over the last five years, there has been a rapid change in treatment strategies for HIV infection. With the advent of newer antiretrovirals, treatment has moved from mono-therapy and bi-therapy to triple drug therapy or Highly Active Antiretroviral Therapy. One of the foremost concerns of ARV programs is the ability of people living with HIV/AIDS to maintain near perfect adherence over the long term. To achieve the goal of antiretroviral therapy (ART), undetectable levels of the virus in the blood, patients are required to maintain more than 90–95% adherence. Adherence is defined as a patient’s ability to follow a treatment plan, take medications at prescribed times and frequencies, and follow restrictions regarding food and other medications. This Adherence Training Manual was developed by the Horizons Program of the Population Council for the Antiretroviral Therapy Program in Mombasa, Kenya. It was designed for health workers including physicians, clinical officers, and adherence nurse counselors in ARV programs. It consists of four modules to be conducted over four sessions, which can be conducted as part of a comprehensive ART training program.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'HIV treatment adherence' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography